Liraglutide: a new option in the management of type 2 diabetes
Future Prescriber · 2008
DOI: 10.1002/fps.10 ↗Kurz gefasst
Fachartikel in der Zeitschrift Future Prescriber, 2008. Verfasst von Milan K Piya und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Type 2 diabetes mellitus (T2DM) is a global epidemic with an expected prevalence of 380 million in 2025 worldwide 1 and over 2.5 million by 2010 in the UK. 2 Diabetes is a progres‐sive disease which leads to macro and microvascular complications and reduced life expectancy. 2 Furthermore, diabetes‐related complications have been shown to worsen patients' quality of life. 3,4 Copyright © 2008 John Wiley & Sons, Ltd.
Zitieren
APA
Piya, M. K., Tahrani, A. A., & Barnett, A. H. (2008). Liraglutide: a new option in the management of type 2 diabetes. Future Prescriber. https://doi.org/10.1002/fps.10
Vancouver
Piya MK, Tahrani AA, Barnett AH. Liraglutide: a new option in the management of type 2 diabetes. Future Prescriber. 2008. doi:10.1002/fps.10
BibTeX
@article{Piya2008,
author = {Piya, Milan K and Tahrani, Abd A and Barnett, Anthony H},
title = {Liraglutide: a new option in the management of type 2 diabetes},
journal = {Future Prescriber},
year = {2008},
doi = {10.1002/fps.10}
}
EUVIMED